Overview
Infectious mononucleosis is a viral illness most commonly caused by the Epstein-Barr virus. It mainly affects adolescents and young adults and is frequently seen during the second decade of life. Although many people may become infected with the Epstein-Barr virus, only a portion develop the clinical illness known as infectious mononucleosis. The disease is characterized by systemic symptoms and lymphoid tissue involvement. The infection spreads mainly through close personal contact and body fluids. Laboratory evaluation plays an important role in confirming the diagnosis and distinguishing it from other infections with similar symptoms.
Symptoms
Patients with infectious mononucleosis commonly present with sore throat, fever, swollen lymph nodes, and persistent fatigue. Throat inflammation and generalized weakness are frequent complaints during the early stage of illness. Enlarged lymph nodes in the neck region are typical findings. Some patients may also develop skin rashes. Enlargement of the spleen and liver may occur in certain cases, reflecting systemic involvement of lymphoid organs. These symptoms usually prompt laboratory testing to confirm the presence of Epstein-Barr virus infection.
Causes
The most common cause of infectious mononucleosis is infection with the Epstein-Barr virus. The virus spreads primarily through saliva and close person-to-person contact. Transmission may also occur through other body fluids such as blood and semen. Less commonly, infection may occur through blood transfusion or organ transplantation. After infection, the virus affects lymphocytes and produces characteristic atypical lymphocytes seen on peripheral blood smear examination. The immune response to the virus leads to the development of specific antibodies that can be detected through laboratory testing.
Risk Factors
Adolescents and young adults have a higher likelihood of developing symptomatic infectious mononucleosis after Epstein Barr virus exposure. Close personal contact increases the risk of transmission because the virus spreads through saliva. Blood transfusion or organ transplantation can also transmit the virus in rare cases. Laboratory evaluation may reveal abnormalities such as atypical lymphocytes on peripheral blood smear, mild thrombocytopenia, neutropenia, and elevated liver function tests. Early testing may occasionally produce negative results because antibodies may not appear immediately after infection, requiring repeat testing after ten days to two weeks if clinical suspicion remains high.
Prevention
Prevention focuses mainly on limiting exposure to infected body fluids and maintaining good hygiene practices. Avoiding close contact with infected individuals and preventing the exchange of saliva can reduce the risk of transmission. Early laboratory investigation helps in identifying the disease and preventing further spread. Diagnostic tests include heterophile antibody testing such as the Monospot test, which provides rapid results. Epstein-Barr virus-specific antibody tests, including VCA IgM, VCA IgG, and EBNA help determine whether the infection is recent, past, or absent. In certain situations, molecular testing using PCR to detect Epstein-Barr virus DNA may be used, especially in severe or atypical cases. Proper interpretation of these laboratory findings allows accurate diagnosis and appropriate clinical management.
